Get the Stockscreener App
37.10
0.24%
0.09
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Forecast
The Kiniksa Pharmaceuticals International Plc (KNSA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $22.23, representing a -40.08% decrease from the current price of $37.10. The highest analyst price target is $25.21, and the lowest is $19.25.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KNSA Price Target
Average 23.74
(-36.02% Downside)
Is Kiniksa Pharmaceuticals International Plc (KNSA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 73.54 | Sell |
| STOCH(9,6) | 91.96 | Sell |
| STOCHRSI(14) | 80.40 | Sell |
| MACD(12,26) | 1.4279 | Buy |
| ADX(14) | 51.81 | Buy |
| William %R | -5.3805 | Sell |
| CCI(14) | 109.86 | Buy |
Buy: 3
Sell: 4
Neutral: 0
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
35.82
Buy
|
35.95
Buy
|
| MA20 |
34.64
Buy
|
34.84
Buy
|
| MA50 |
31.75
Buy
|
32.45
Buy
|
| MA100 |
29.34
Buy
|
29.82
Buy
|
| MA200 |
24.99
Buy
|
27.16
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, KNSA could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 4 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on KNSA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 73.54 indicates that KNSA is overbought. This suggests that KNSA price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 91.96 indicates that KNSA is oversold. This means that KNSA price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 80.4 indicates that KNSA is oversold. This suggests that KNSA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 51.81 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 109.86 indicates that KNSA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term KNSA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kiniksa Pharmaceuticals International Plc financial reports and earnings history, Kiniksa Pharmaceuticals International Plc (KNSA) stock could reach $25.79 by 2030, $28.27 by 2040 and $36.92 by 2050. See the projected annual prices until 2050 of the Kiniksa Pharmaceuticals International Plc stock below:
- Kiniksa Pharmaceuticals International Plc (KNSA) is expected to reach an average price of $27.11 in 2035, with a high prediction of $27.92 and a low estimate of $25.24. This indicates an $-26.94% rise from the last recorded price of $37.10.
- Kiniksa Pharmaceuticals International Plc (KNSA) stock is projected to chart a bullish course in 2040, with an average price target of $27.01, representing an $-27.21% surge from its current level. The forecast ranges from a conservative $26.51 to a sky-high $28.27.
- Our analysts predict Kiniksa Pharmaceuticals International Plc (KNSA) to jump -5.70% by 2045, soaring from $31.18 to an average price of $34.98, potentially reaching $35.48. While $31.18 is the low estimate, the potential upside is significant.
- Kiniksa Pharmaceuticals International Plc (KNSA) stock is expected to climb by 2050, reaching an average of $36.62, a $-1.28% jump from its current level. However, a wide range of estimates exists, with high and low targets of $36.92 and $34.69, respectively, highlighting the market's uncertainty.
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Year by Year Forecast
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2025
Kiniksa Pharmaceuticals International Plc Stock (KNSA) is expected to reach an average price of $24.24 in 2025, with a high prediction of $33.34 and a low estimate of $15.14. This indicates an -34.67% fall from the last recorded price of $37.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2025 | $20.11 | $19.25 | $25.21 | -45.80% |
| November, 2025 | $20.08 | $19.67 | $22.70 | -45.89% |
| December, 2025 | $20.44 | $19.36 | $26.01 | -44.91% |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2026
The predicted value for Kiniksa Pharmaceuticals International Plc (KNSA) in 2026 is set at an average of $22.94. Estimates vary from a peak of $29.56 to a trough of $16.32, indicating an -38.18% surge from the present price of $37.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $23.06 | $19.34 | $23.22 | -37.86% |
| February, 2026 | $24.26 | $21.50 | $25.30 | -34.60% |
| March, 2026 | $24.68 | $21.48 | $25.18 | -33.48% |
| April, 2026 | $28.82 | $21.68 | $29.37 | -22.31% |
| May, 2026 | $25.01 | $24.62 | $29.56 | -32.59% |
| June, 2026 | $22.58 | $20.59 | $25.63 | -39.14% |
| July, 2026 | $19.04 | $18.68 | $22.60 | -48.68% |
| August, 2026 | $19.79 | $17.92 | $20.37 | -46.67% |
| September, 2026 | $19.47 | $18.44 | $20.23 | -47.52% |
| October, 2026 | $18.09 | $17.60 | $21.65 | -51.25% |
| November, 2026 | $17.56 | $16.50 | $18.30 | -52.66% |
| December, 2026 | $16.40 | $16.32 | $18.23 | -55.81% |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kiniksa Pharmaceuticals International Plc (KNSA) is $16.41, with a high forecast of $20.28 and a low forecast of $12.55. This indicates an -55.76% decrease from the last price of $37.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $15.74 | $15.63 | $16.88 | -57.57% |
| February, 2027 | $17.24 | $15.33 | $20.28 | -53.53% |
| March, 2027 | $18.68 | $16.23 | $19.28 | -49.64% |
| April, 2027 | $16.41 | $15.64 | $18.83 | -55.77% |
| May, 2027 | $15.40 | $15.05 | $16.96 | -58.50% |
| June, 2027 | $14.69 | $14.61 | $16.76 | -60.40% |
| July, 2027 | $15.08 | $14.18 | $16.41 | -59.36% |
| August, 2027 | $15.24 | $15.00 | $16.64 | -58.94% |
| September, 2027 | $13.25 | $12.73 | $15.56 | -64.29% |
| October, 2027 | $14.31 | $12.55 | $14.37 | -61.42% |
| November, 2027 | $16.28 | $14.18 | $16.86 | -56.11% |
| December, 2027 | $17.64 | $14.86 | $18.98 | -52.44% |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2028
In 2028, Kiniksa Pharmaceuticals International Plc (KNSA) is projected to reach an average price of $18.95, with a high projection of $22.51 and a low estimate of $15.40. This indicates an -48.91% fall from the last price of $37.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $16.69 | $16.51 | $18.23 | -55.01% |
| February, 2028 | $18.11 | $15.40 | $18.30 | -51.19% |
| March, 2028 | $16.71 | $16.49 | $19.78 | -54.96% |
| April, 2028 | $21.07 | $17.30 | $22.09 | -43.21% |
| May, 2028 | $20.79 | $19.93 | $22.51 | -43.96% |
| June, 2028 | $19.40 | $19.15 | $21.74 | -47.71% |
| July, 2028 | $19.26 | $18.91 | $20.19 | -48.10% |
| August, 2028 | $17.38 | $17.10 | $19.81 | -53.16% |
| September, 2028 | $16.12 | $15.70 | $17.71 | -56.56% |
| October, 2028 | $19.11 | $15.70 | $19.62 | -48.48% |
| November, 2028 | $20.05 | $18.37 | $20.10 | -45.94% |
| December, 2028 | $19.54 | $19.50 | $22.27 | -47.33% |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2029
The 2029 price forecast for Kiniksa Pharmaceuticals International Plc Stock (KNSA) is $23.38 on average, with a high prediction of $27.74 and a low estimate of $19.03. This represents an -36.98% decrease from the previous price of $37.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $24.32 | $19.03 | $26.13 | -34.44% |
| February, 2029 | $22.95 | $21.71 | $24.66 | -38.14% |
| March, 2029 | $22.66 | $22.11 | $23.40 | -38.92% |
| April, 2029 | $21.85 | $20.77 | $23.52 | -41.11% |
| May, 2029 | $20.00 | $19.68 | $22.37 | -46.09% |
| June, 2029 | $22.39 | $19.74 | $22.41 | -39.66% |
| July, 2029 | $23.13 | $22.05 | $24.74 | -37.64% |
| August, 2029 | $23.25 | $23.19 | $25.96 | -37.34% |
| September, 2029 | $25.63 | $23.14 | $26.57 | -30.91% |
| October, 2029 | $25.63 | $24.81 | $27.74 | -30.93% |
| November, 2029 | $22.58 | $22.23 | $25.98 | -39.13% |
| December, 2029 | $23.80 | $22.55 | $25.61 | -35.85% |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2030
Kiniksa Pharmaceuticals International Plc Stock (KNSA) is expected to reach an average price of $21.63 in 2030, with a high forecast of $29.21 and a low forecast of $14.04. This signifies an -41.71% decrease from the last price of $37.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.43 | $21.89 | $25.79 | -39.53% |
| February, 2030 | $22.72 | $21.91 | $25.65 | -38.76% |
| March, 2030 | $20.33 | $19.72 | $23.40 | -45.19% |
| April, 2030 | $17.85 | $17.80 | $20.66 | -51.89% |
| May, 2030 | $17.53 | $17.01 | $19.45 | -52.74% |
| June, 2030 | $15.03 | $14.04 | $17.56 | -59.49% |
| July, 2030 | $18.61 | $14.98 | $18.66 | -49.85% |
| August, 2030 | $22.03 | $18.42 | $23.62 | -40.61% |
| September, 2030 | $23.32 | $19.82 | $24.77 | -37.14% |
| October, 2030 | $26.52 | $22.39 | $27.98 | -28.51% |
| November, 2030 | $24.72 | $23.22 | $29.21 | -33.37% |
| December, 2030 | $26.48 | $19.75 | $27.49 | -28.63% |
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):